Skip to main content
AXSM logo
AXSM
(NASDAQ)
Axsome Therapeutics, Inc.
$247.85-- (--)
Loading... - Market loading

Axsome Therapeutics (AXSM) Stock Price & Financial Analysis

Axsome Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$245.94 - $253.00
52-Week High$260.19
52-Week Low$96.09
Open$249.05
Volume776.84K
Average Volume (3M)667.83K
Market Cap12.83B
Shares Outstanding51.20M
Price to Sales (P/S)18.11
Price to Book (P/B)234.95
EV/EBITDA-77.56
Revenue (TTM)708.24M
Net Income (TTM)-188.30M
Free Cash Flow (TTM)-70.99M
EPS (TTM)$-3.74
Profit Margin-26.59%
Operating Margin-22.93%
Return on Equity (ROE)-344.96%
Debt to Equity3.44
50-Day MA$218.02
200-Day MA$168.12
52-Week Change143.46%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Axsome Therapeutics

What is the current stock price for AXSM?

As of the latest trading session, AXSM stock trades at $247.85. The 52-week range is $96.09–$260.19, with a day range of $245.94–$253.00.

What is the P/E ratio for AXSM?

The P/E ratio (Price-to-Earnings) for AXSM is shown in the Key Statistics section. This valuation metric helps compare Axsome Therapeutics, Inc. to industry peers.

Does AXSM pay dividends?

Axsome Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AXSM?

Based on 17 analysts, the consensus for AXSM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AXSM?

Axsome Therapeutics's market capitalization is $12.69B, classifying it as a large-cap company. Axsome Therapeutics operates in the Healthcare sector within the Biotechnology industry.